https://ift.tt/3gKfYgk The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Bharat Biotech submits Covaxin's Phase III trial data to DCGI: Govt sources
Reviewed by MITESH
on
June 21, 2021
Rating: 5
No comments